Evidence map›Paper›PMID 28209656›Full record

ArticleHaematologica2017

Changes in allele frequencies of

Zohra Nooruddin, Nicholas Miltgen, Qi Wei, Jeffrey Schowinsky, Zengang Pan, Jennifer Tobin, Enkhtsetseg Purev, Jonathan A Gutman, William Robinson, Daniel A Pollyea

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Rare evolution ofLeukemia research reports · 2022
    Article
  8. Review
  9. Current Management of Chronic Neutrophilic Leukemia.Current treatment options in oncology · 2021
    Review
  10. Article
  11. Review
  12. [Ruxolitinib for chronic neutrophilic leukemia: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018
    Article
  13. Article
  14. Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Article
  15. Article
  16. Review
  17. Review
  18. Oncotarget · 2017
    Review
  19. Somatic SETBP1 mutations in myeloid neoplasms.International journal of hematology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zohra NooruddinUniversity of Colorado Division of Hematology, Aurora, CO, USA.
Nicholas MiltgenChildren's Hospital of Colorado, Department of Pathology, Aurora, CO, USA.
Qi WeiChildren's Hospital of Colorado, Department of Pathology, Aurora, CO, USA.
Jeffrey SchowinskyUniversity of Colorado Department of Pathology, Aurora, CO, USA.
Zengang PanUniversity of Colorado Department of Pathology, Aurora, CO, USA.
Jennifer TobinUniversity of Colorado School of Pharmacy, Aurora, CO, USA.
Enkhtsetseg PurevUniversity of Colorado Division of Hematology, Aurora, CO, USA.
Jonathan A GutmanUniversity of Colorado Division of Hematology, Aurora, CO, USA.
William RobinsonUniversity of Colorado Division of Hematology, Aurora, CO, USA.
Daniel A PollyeaUniversity of Colorado Division of Hematology, Aurora, CO, USA daniel.pollyea@ucdenver.edu.
University of Colorado Denver · USChildren's Hospital Colorado · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene FrequencyMutationAntineoplastic AgentsBone MarrowCarrier ProteinsClonal EvolutionDisease ProgressionHumansLeukemia, Neutrophilic, ChronicLeukocyte CountNitrilesNuclear ProteinsProtein Kinase InhibitorsPyrazolesPyrimidinesReceptors, Colony-Stimulating FactorAntineoplastic AgentsCarrier ProteinsCSF3R protein, humanNitrilesNuclear ProteinsProtein Kinase InhibitorsPyrazolesPyrimidinesReceptors, Colony-Stimulating FactorruxolitinibSETBP1 protein, human

Identifiers

PMID28209656
PMCPMC5477626
OpenAlexW2588697275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.